Development of antimicrobial peptides for catheter-related bloodstream infectionprevention by unknown
INNOVATION ACADEMY PRESENTATION Open Access
Development of antimicrobial peptides for
catheter-related bloodstream infectionprevention
TA Camesano*, T Alexander, L Lozeau
From 3rd International Conference on Prevention and Infection Control (ICPIC 2015)
Geneva, Switzerland. 16-19 June 2015
Introduction
Central venous catheters are used in many medical proce-
dures to deliver critical and lifesaving treatments, such as
antibiotics and chemotherapy agents. However, central
line-associated bloodstream infections (CLABSIs) asso-
ciated with these devices negatively impact over 100,000
patients per year and are extremely expensive to treat.
When infections arise on implanted biomaterials, they
are treated with systemic antibiotics, debridement, and
implant removal. Unfortunately, the high local antibiotic
concentrations needed to kill colonized bacteria are only
achieved over a short time, cause cytotoxicity, and can
promote antibacterial resistance. Therefore, it is currently
believed that proactive methods of infection management
will be superior to reactive methods.
As an alternative to traditional antibiotics or to device
removal, antimicrobial peptides (AMPs) represent a
novel way to prevent and treat infections. AMPs are
short, cationic molecules found naturally in the innate
immune systems of many species, and they have broad
spectrum antimicrobial activity. AMPs use fundamentally
different mechanisms to kill bacteria than conventional
antibiotics, reducing the threat of bacterial resistance.
Objectives
The objective of our overall research program is to
improve biomedical devices using a therapy based on sur-
face-tethered AMPs. Although AMPs are highly active
against bacteria when free in solution, immobilization of
AMPs to a surface significantly reduces antimicrobial
activity.
Methods
Antimicrobial peptides are tethered to biomaterial sur-
faces using flexible chemical linkers. We are currently
investigating the role of the linker size in influencing the
efficacy of the antimicrobial peptide. Activity against
Gram-negative and Gram-positive bacteria is being quan-
tified. We are also studying the cytotoxicty and long-term
stability of the tethered peptides.
Results
We have shown that modified antimicrobial peptide, chry-
sophsin-1, can be chemically tethered to a biomaterial sur-
face using polyethylene glycol as a spacer. Killing was
observed for Staphylococcus aureus and Escherichia coli.
Conclusion
The expected outcome of this project is a surface modifi-
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